Results are explorative but indicate that DPSCs can down-regulate the production of cytokines by activated PBMCs, e.g., TNFα, IFNγ, IL-10, and IL-17A, which are up-regulated in COVID-19 patients. This evidence concerns the gene IFNG and COVID-19.